BSE filing, NSE: APLLTD. Summary written from the filing by ALFA Finder's alert engine.
Alembic Pharmaceuticals Ltd: key numbers
- Share price
- ₹797.85
- Market cap
- ₹15,683 Cr
- Revenue (annual)
- ₹7,345 Cr
- Net profit (annual)
- ₹674.8 Cr
- P/E (TTM)
- 22.6×Sector 45.9×
- Promoter holding
- 69.87%+0.00% QoQ
- FII holding
- 4.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alembic Pharmaceuticals Ltd
All →Alembic Pharmaceuticals Board Meeting Date
Alembic Pharmaceuticals scheduled its board meeting for November 4, 2026, to consider unaudited Q1/H1 FY27 results. Trading window re-opens 48 hours post-declaration.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.
Alembic Pharmaceuticals Merger & Restructuring Worth ₹0.26 Cr
Alembic Pharmaceuticals' subsidiary, Alembic Global Holding SA, incorporated a new wholly-owned subsidiary, Alvesta Pharmaceuticals FZCO, in the UAE for Rs. 0.26 Crore.
- Value
- ₹0.26 Cr
Alembic Pharmaceuticals Merger & Restructuring Worth ₹0.23 Cr
Alembic Pharmaceuticals' wholly-owned subsidiary, Alembic Global Holding SA, incorporated a new step-down subsidiary, Alvesta Pharmaceuticals FZCO, in Dubai for AED 1 Lakh (approx. ₹0.23 Crore).
- Value
- ₹0.23 Cr
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for Ciprofloxacin and Dexamethasone Otic Suspension USP. This drug is therapeutically equivalent to the reference product Ciprodex Otic Suspension.
Alembic Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Other dividend announcements
All →NTPC Dividend
NTPC Limited's board approved an interim dividend of Rs 3 per equity share for FY 2026-27 on 31 October 2026. Record date is 6 November 2026 and payment by 25 November 2026.
Share India Securities Dividend
Share India Securities declared a second interim dividend of Rs 0.40 per share for FY2026-27. The record date is 5 November 2026, with payment by 27 November 2026.
Quess Corp Dividend
QUESS CORP LIMITED's board meeting held 30 Oct 2026 approved an interim dividend of Rs.5 per share for FY 2026-27. Record date is 6 November 2026 and payment is due by 20 November 2026.
Gabriel India Dividend
Gabriel India declared an interim dividend of Rs 2.15 per share on 30 October 2026. Record date is 6 November 2026; payment due by 28 November.
Shreeji Translogistics Dividend
Shreeji Translogistics declared an interim dividend of Rs 0.05 per share for FY 2026-27 at its 30 October board meeting. Record date is 6 November 2026.
Ramkrishna Forgings Dividend
Ramkrishna Forgings declared an interim dividend of Rs 2 per equity share for FY2026-27 on October 30, 2026. The record date is November 6, 2026, with payment by November 29, 2026.